Owkin invests $50M in spatial omics project that will 'revolutionize cancer research' 08-Jun-2023 By Liza Laws Artificial intelligence (AI) biotech company, Owkin, has invested $50million in a project that will use spatial omics, a set of cutting-edge technologies that offer unprecedented information on the structure of tumors.